Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-23

Clinical Trial Update: The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating atorvastatin calcium salt and simvastatin-acid sodium salt for repigmentation in active non-segmental vitiligo; study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atorvastatin calcium salt (atorvastatin)
  • simvastatin-acid sodium salt (simvastatin)

Snippet

Sponsor: Nicolaus Copernicus University | Conditions: Non-segmental Vitiligo | Phase 1, Phase 2 | Status: COMPLETED